BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10471090)

  • 1. Effects of nimodipine on extracellular dopamine levels in the rat nucleus accumbens in ethanol withdrawal.
    Rossetti ZL; Isola D; De Vry J; Fadda F
    Neuropharmacology; 1999 Sep; 38(9):1361-9. PubMed ID: 10471090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acupuncture normalizes the release of accumbal dopamine during the withdrawal period and after the ethanol challenge in chronic ethanol-treated rats.
    Zhao RJ; Yoon SS; Lee BH; Kwon YK; Kim KJ; Shim I; Choi KH; Kim MR; Golden GT; Yang CH
    Neurosci Lett; 2006 Feb; 395(1):28-32. PubMed ID: 16289320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats: electrophysiological and biochemical evidence.
    Diana M; Pistis M; Carboni S; Gessa GL; Rossetti ZL
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):7966-9. PubMed ID: 8367449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In alcohol-treated rats, naloxone decreases extracellular dopamine and increases acetylcholine in the nucleus accumbens: evidence of opioid withdrawal.
    Rada P; Johnson DF; Lewis MJ; Hoebel BG
    Pharmacol Biochem Behav; 2004 Dec; 79(4):599-605. PubMed ID: 15582668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome.
    Hildebrand BE; Nomikos GG; Hertel P; Schilström B; Svensson TH
    Brain Res; 1998 Jan; 779(1-2):214-25. PubMed ID: 9473676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nicotine and mecamylamine-induced withdrawal on extracellular dopamine and acetylcholine in the rat nucleus accumbens.
    Rada P; Jensen K; Hoebel BG
    Psychopharmacology (Berl); 2001 Aug; 157(1):105-10. PubMed ID: 11512050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesolimbic dopaminergic reduction outlasts ethanol withdrawal syndrome: evidence of protracted abstinence.
    Diana M; Pistis M; Muntoni A; Gessa G
    Neuroscience; 1996 Mar; 71(2):411-5. PubMed ID: 9053796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell.
    Paterson NE; Balfour DJ; Markou A
    Eur J Neurosci; 2007 May; 25(10):3099-108. PubMed ID: 17561823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced levels of Cacna1c attenuate mesolimbic dopamine system function.
    Terrillion CE; Dao DT; Cachope R; Lobo MK; Puche AC; Cheer JF; Gould TD
    Genes Brain Behav; 2017 Jun; 16(5):495-505. PubMed ID: 28186690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine stimulation on extracellular glutamate levels in the nucleus accumbens of ethanol-withdrawn rats in vivo.
    Saellstroem Baum S; Huebner A; Krimphove M; Morgenstern R; Badawy AA; Spies CD
    Alcohol Clin Exp Res; 2006 Aug; 30(8):1414-21. PubMed ID: 16899045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of ketamine effects by nimodipine pretreatment in recovering ethanol dependent men: psychopharmacologic implications of the interaction of NMDA and L-type calcium channel antagonists.
    Krupitsky EM; Burakov AM; Romanova TN; Grinenko NI; Grinenko AY; Fletcher J; Petrakis IL; Krystal JH
    Neuropsychopharmacology; 2001 Dec; 25(6):936-47. PubMed ID: 11750186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repetitive transcranial magnetic stimulation increases the release of dopamine in the nucleus accumbens shell of morphine-sensitized rats during abstinence.
    Erhardt A; Sillaber I; Welt T; Müller MB; Singewald N; Keck ME
    Neuropsychopharmacology; 2004 Nov; 29(11):2074-80. PubMed ID: 15187982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced dopamine release in the nucleus accumbens core of adult rats following adolescent binge alcohol exposure: age and dose-dependent analysis.
    Zandy SL; Matthews DB; Tokunaga S; Miller A; Blaha CD; Mittleman G
    Psychopharmacology (Berl); 2015 Feb; 232(4):777-784. PubMed ID: 25116483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats.
    Rossetti ZL; Hmaidan Y; Gessa GL
    Eur J Pharmacol; 1992 Oct; 221(2-3):227-34. PubMed ID: 1426002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of local and systemic ethanol effects on extracellular dopamine concentration in rat nucleus accumbens by microdialysis.
    Yim HJ; Schallert T; Randall PK; Gonzales RA
    Alcohol Clin Exp Res; 1998 Apr; 22(2):367-74. PubMed ID: 9581642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic dihydropyridine treatment can reverse the behavioural consequences of and prevent adaptations to, chronic ethanol treatment.
    Whittington MA; Dolin SJ; Patch TL; Siarey RJ; Butterworth AR; Little HJ
    Br J Pharmacol; 1991 Jul; 103(3):1669-76. PubMed ID: 1834295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration.
    Weiss F; Markou A; Lorang MT; Koob GF
    Brain Res; 1992 Oct; 593(2):314-8. PubMed ID: 1450939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marked decrease of A10 dopamine neuronal firing during ethanol withdrawal syndrome in rats.
    Diana M; Pistis M; Muntoni A; Rossetti ZL; Gessa G
    Eur J Pharmacol; 1992 Oct; 221(2-3):403-4. PubMed ID: 1426019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on a model of long term alcohol drinking.
    Holt JD; Watson WP; Little HJ
    Behav Brain Res; 2001 Sep; 123(2):193-200. PubMed ID: 11399331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of pyrethroid insecticides on extracellular dopamine in the striatum of freely moving rats.
    Mubarak Hossain M; Suzuki T; Sato N; Sato I; Takewaki T; Suzuki K; Tachikawa E; Kobayashi H
    Toxicol Appl Pharmacol; 2006 Nov; 217(1):25-34. PubMed ID: 16956637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.